Jim Cramer Says Don't Get Too Excited About COVID-19 Treatment News
The World Health Organization advised doctors against using remdesivir--Gilead's antiviral drug--as a treatment for patients hospitalized with COVID-19.
The WHO said there is currently “no evidence” that it improves survival rates or the need for ventilation in a report published in The BMJ, the British Medical Journal.
According to the report, the largest trial to date of treatments repurposed for use in the Covid-19 pandemic has shown that none of the four drugs studied produced any measurable benefit in mortality or disease course. “This includes remdesivir--a drug already recommended by several guidelines and pre-ordered by numerous governments around the world.”
Watch: Everything Jim Cramer Is Watching in Markets Friday
